You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prostate Cancer - High Risk Localized or Locally Advanced

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy Trial in

Recruiting
  • Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer center
Dec 28, 2021

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Advanced Prostate Cancer Trial in Baltimore (Pelvic DCFPyL PET-MRI fusion or PET/MRI)

Recruiting
  • Advanced Prostate Cancer
  • Pelvic DCFPyL PET-MRI fusion or PET/MRI
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 22, 2022

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Prostate Cancer Trial in Boston (Docetaxel, Androgen Hormonal Suppression and Radiation, Androgen Suppression Therapy and

Completed
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
Jan 6, 2022

Prostatic Tumors Trial in Austria, Germany (Standard of care, Apalutamide 60Mg Tab)

Recruiting
  • Prostatic Neoplasms
  • Standard of care
  • Apalutamide 60Mg Tab
  • Innsbruck, Austria
  • +24 more
May 5, 2022

Androgen Deprivation Therapy, Locally Advanced Prostate Cancer Trial in Oklahoma City (Relugolix and Enzalutamide)

Not yet recruiting
  • Androgen Deprivation Therapy
  • Locally Advanced Prostate Cancer
  • Relugolix and Enzalutamide
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center at OU Health, University of Oklahoma He
Nov 8, 2023

Prostate Cancer Trial in Beijing (Darolutamide+ADT)

Not yet recruiting
  • Prostate Cancer
  • Beijing, China
    Peking University First Hospital
Sep 1, 2023

Prostate Cancer, Radical Prostatectomy Trial in Houston (REGN5678, Piflufolastat F18)

Not yet recruiting
  • Prostate Cancer
  • Radical Prostatectomy
  • Houston, Texas
    MD Anderson Cancer Center
Oct 10, 2023

Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer Trial in Nanjing (ADT, Abiraterone Acetate,

Recruiting
  • Neoadjuvant Therapy
  • +3 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Aug 12, 2022

Prostate Cancer Trial in Baltimore (Enoblituzumab, Standard of Care)

Not yet recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Aug 25, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

Not yet recruiting
  • High-Risk Prostate Cancer
  • Portland, Oregon
    VA Portland Health Care System, Portland, OR
Jan 17, 2023

Prostate Cancer Trial in France (Surgery alone, Peri-operative darolutamide + surgery.)

Not yet recruiting
  • Prostate Cancer
  • Surgery alone
  • Peri-operative darolutamide + surgery.
  • Angers, France
  • +10 more
Apr 12, 2023

Recurrent Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Stage I Skin Cancer Trial in Los Angeles,

Recruiting
  • Recurrent Skin Squamous Cell Carcinoma
  • +4 more
  • Cemiplimab
  • Resection
  • Los Angeles, California
  • +2 more
Nov 12, 2022

Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

Not yet recruiting
  • Localized Prostate Carcinoma
  • +3 more
  • Degarelix
  • MRI-guided transurethral ultrasound ablation (TULSA)
  • Turku, Southwest Finland, Finland
    Turku University Hospital
Jun 14, 2023

Localized Prostate Cancer Participants Treated With Radical

Not yet recruiting
  • High Risk Localized Prostate Cancer
    • Akita, Japan
      Akita University Hospital
    Aug 2, 2022

    Prostate Cancer, Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen Trial in San

    Recruiting
    • Prostate Cancer
    • Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen
    • TRANBERG®|Thermal Therapy System
    • San Diego, California
      Genesis Research LLC.
    Apr 12, 2023

    Men Undergoing Brachytherapy for Prostate Cancer

    Not yet recruiting
    • Prostate Cancer
      • Baltimore, Maryland
        Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
      Oct 11, 2022

      Prostate Cancer Trial (Hypofractionated IMRT Radiation treatment)

      Active, not recruiting
      • Prostate Cancer
      • Hypofractionated IMRT Radiation treatment
      • (no location specified)
      Sep 27, 2022

      Locally Advanced and Metastatic Prostate Cancer Trial in Vienna (Radical prostatectomy)

      Recruiting
      • Locally Advanced and Metastatic Prostate Cancer
      • Radical prostatectomy
      • Vienna, Austria
        Medical University of Vienna
      Apr 4, 2022

      Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)

      Recruiting
      • Cervical Cancer
      • +2 more
      • Tianjin, Tianjin, China
        Tianjin Medical University Cancer Institute & Hospital
      Oct 16, 2023

      Combined Postoperative Radiotherapy With Kidney Sparing Surgery

      Recruiting
      • Locally Advanced
      • Urothelial Carcinoma Ureter
      • Radical surgery
      • Kidney sparing surgery+Postoperative radiotheray
      • Beijing, China
      • +1 more
      Nov 2, 2023

      Breast Cancer, Neoadjuvant Therapy Trial in Beijing (Utidelone, Carboplatin, Epirubicin)

      Not yet recruiting
      • Breast Cancer
      • Neoadjuvant Therapy
      • Beijing, Beijing, China
        Cancer Hospital, Chinese Academy of Medical Sciences
      Aug 1, 2023

      Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)

      Not yet recruiting
      • Locally Advanced
      • +3 more
      • Guangzhou, Guangdong, China
        Nanfang Hospital Southern Medical University
      May 17, 2023